We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.85B
AUM Growth
-$635M
Cap. Flow
+$29.4M
Cap. Flow %
0.61%
Top 10 Hldgs %
50.96%
Holding
1,406
New
286
Increased
340
Reduced
405
Closed
335
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
4.9 quarters
Top 20 Avg Time Held Equity + Options
6.2 quarters
Avg Time Held Equity only
1.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$24.2M
2
META icon
Meta Platforms (Facebook)
META
+$23.3M
3
NFLX icon
Netflix
NFLX
+$9.98M
4
AVGO icon
Broadcom
AVGO
+$6.87M
5
AABA
Altaba Inc
AABA
+$6.36M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$13.5M
2
XOM icon
ExxonMobil
XOM
+$10.4M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$6.62M
4
INTC icon
Intel
INTC
+$6.23M
5
MSFT icon
Microsoft
MSFT
+$5.26M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.61%
2 Technology 1.76%
3 Communication Services 1.6%
4 Energy 0.75%
5 Consumer Discretionary 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QRVO icon
801
CALL
DELISTED
Qorvo
QRVO
$367K 0.01%
5,800
+700
+14% +$50K
2016 Q4
2 quarters
F icon
802
PUT
Ford
F
$48.2B
$364K 0.01%
32,500
+19,600
+152% +$219K
2013 Q4
14 quarters
BHC icon
803
Bausch Health
BHC
$2.2B
$362K 0.01%
20,914
+2,565
+14% +$30.7K
2017 Q1
1 quarter
GSK icon
804
CALL
GSK
GSK
$92.7B
$362K 0.01%
6,720
+1,200
+22% +$64K
2015 Q4
6 quarters
GWPH
805
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$361K 0.01%
3,600
+1,400
+64% +$151K
2017 Q1
1 quarter
CQP icon
806
Cheniere Energy
CQP
$31.3B
$360K 0.01%
11,104
-1,796
-14% -$57.3K
2017 Q1
1 quarter
DUK icon
807
Duke Energy
DUK
$92.2B
$359K 0.01%
4,298
+1,300
+43% +$109K
2017 Q1
1 quarter
HSBC icon
808
PUT
HSBC
HSBC
$324B
$357K 0.01%
8,427
-36,960
-81% -$1.43M
2017 Q1
1 quarter
MO icon
809
CALL
Altria Group
MO
$119B
$357K 0.01%
4,800
-200
-4% -$14.6K
2016 Q2
4 quarters
BHP icon
810
CALL
BHP
BHP
$216B
$356K 0.01%
11,210
+3,363
+43% +$107K
2015 Q4
6 quarters
FLR icon
811
Fluor
FLR
$6.65B
$356K 0.01%
7,783
+1,639
+27% +$78.4K
2017 Q1
1 quarter
COF icon
812
CALL
Capital One
COF
$122B
$355K 0.01%
+4,300
New +$349K
2017 Q2
0 quarters
TPR icon
813
CALL
Tapestry
TPR
$23B
$355K 0.01%
+7,500
New +$329K
2017 Q2
0 quarters
TPR icon
814
PUT
Tapestry
TPR
$23B
$355K 0.01%
7,500
-25,000
-77% -$1.1M
2016 Q4
2 quarters
CPRI icon
815
PUT
Capri Holdings
CPRI
$1.72B
$352K 0.01%
9,700
-29,200
-75% -$1.06M
2016 Q4
2 quarters
PXD icon
816
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$351K 0.01%
2,200
-26,400
-92% -$4.51M
2015 Q3
7 quarters
WFT
817
DELISTED
Weatherford International plc
WFT
$349K 0.01%
+90,081
New +$458K
2017 Q2
0 quarters
UTHR icon
818
United Therapeutics
UTHR
$23.3B
$348K 0.01%
2,686
-84
-3% -$10.5K
2017 Q1
1 quarter
VALE icon
819
Vale
VALE
$56.9B
$347K 0.01%
39,654
+16,450
+71% +$140K
2017 Q1
1 quarter
CNQ icon
820
PUT
Canadian Natural Resources
CNQ
$107B
$346K 0.01%
+24,504
New +$369K
2017 Q2
0 quarters
CTRA icon
821
PUT
DELISTED
Coterra Energy
CTRA
$346K 0.01%
+13,800
New +$326K
2017 Q2
0 quarters
A icon
822
PUT
Agilent Technologies
A
$48.4B
$344K 0.01%
+5,800
New +$330K
2017 Q2
0 quarters
TCRT icon
823
CALL
Alaunos Therapeutics
TCRT
$7.7M
$343K 0.01%
+367
New +$360K
2017 Q2
0 quarters
CRC icon
824
CALL
DELISTED
California Resources Corporation
CRC
$342K 0.01%
40,000
-1,200
-3% -$14.1K
2016 Q4
2 quarters
FN icon
825
PUT
Fabrinet
FN
$15.3B
$341K 0.01%
+8,000
New +$301K
2017 Q2
0 quarters

Similar funds

Integral Derivatives's Q2 2017 Portfolio in Review

As of Q2 2017, Integral Derivatives held 1,406 positions worth $4.85B, down 12% from $5.49B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Integral Derivatives's Q2 2017 filing shows 286 new, 340 increased, 405 reduced and 335 closed positions. Its largest new stake was Broadcom: 296,230 shares worth $6.9M. The largest sale was IBM, an estimated $13.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Technology and Communication Services.

  • Integral Derivatives's largest Q2 2017 buy was Broadcom: 296,230 shares worth $6.9M.
  • Integral Derivatives added most to Apple in Q2 2017, an estimated $24.2M increase.
  • Integral Derivatives's biggest Q2 2017 reduction was IBM, cutting an estimated $13.5M.
  • Integral Derivatives fully exited Intel in Q2 2017, selling an estimated $6.23M.
  • Integral Derivatives's ten largest holdings make up 51% of its $4.85B portfolio in Q2 2017.
  • Integral Derivatives opened 286 new positions and closed 335 in Q2 2017.
  • Integral Derivatives's portfolio value fell 12% quarter-over-quarter to $4.85B.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.